JP2004521140A5 - - Google Patents

Download PDF

Info

Publication number
JP2004521140A5
JP2004521140A5 JP2002574997A JP2002574997A JP2004521140A5 JP 2004521140 A5 JP2004521140 A5 JP 2004521140A5 JP 2002574997 A JP2002574997 A JP 2002574997A JP 2002574997 A JP2002574997 A JP 2002574997A JP 2004521140 A5 JP2004521140 A5 JP 2004521140A5
Authority
JP
Japan
Prior art keywords
administered
flavopiridol
days
taxotere
medicament according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002574997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004521140A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/004083 external-priority patent/WO2002076484A2/en
Publication of JP2004521140A publication Critical patent/JP2004521140A/ja
Publication of JP2004521140A5 publication Critical patent/JP2004521140A5/ja
Pending legal-status Critical Current

Links

JP2002574997A 2001-03-23 2002-03-22 タキサンおよびサイクリン−依存性キナーゼの組み合わせ Pending JP2004521140A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US27794801P 2001-03-23 2001-03-23
US30269201P 2001-07-05 2001-07-05
US33491601P 2001-12-04 2001-12-04
PCT/EP2002/004083 WO2002076484A2 (en) 2001-03-23 2002-03-22 Combination of a taxane and a cyclin-dependent kinase inhibitor

Publications (2)

Publication Number Publication Date
JP2004521140A JP2004521140A (ja) 2004-07-15
JP2004521140A5 true JP2004521140A5 (enExample) 2005-12-22

Family

ID=27402954

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002574997A Pending JP2004521140A (ja) 2001-03-23 2002-03-22 タキサンおよびサイクリン−依存性キナーゼの組み合わせ

Country Status (33)

Country Link
US (2) US20020182204A1 (enExample)
EP (1) EP1372652B1 (enExample)
JP (1) JP2004521140A (enExample)
KR (1) KR100879712B1 (enExample)
CN (1) CN1498107A (enExample)
AR (1) AR034222A1 (enExample)
AT (1) ATE395917T1 (enExample)
AU (1) AU2002312815B2 (enExample)
BR (1) BR0208221A (enExample)
CA (1) CA2441441C (enExample)
CY (1) CY1110449T1 (enExample)
CZ (1) CZ301423B6 (enExample)
DE (1) DE60226710D1 (enExample)
DK (1) DK1372652T3 (enExample)
EA (1) EA007815B1 (enExample)
ES (1) ES2305253T3 (enExample)
HR (1) HRPK20030766B3 (enExample)
HU (1) HU229258B1 (enExample)
IL (2) IL158058A0 (enExample)
ME (1) MEP16408A (enExample)
MX (1) MXPA03007743A (enExample)
NO (1) NO332441B1 (enExample)
NZ (1) NZ527655A (enExample)
PE (1) PE20020907A1 (enExample)
PL (1) PL206118B1 (enExample)
PT (1) PT1372652E (enExample)
RS (1) RS50681B (enExample)
SI (1) SI1372652T1 (enExample)
SK (1) SK287481B6 (enExample)
TW (1) TWI355935B (enExample)
UY (1) UY27220A1 (enExample)
WO (1) WO2002076484A2 (enExample)
ZA (1) ZA200307381B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1487434B1 (en) * 2002-03-06 2007-05-09 The Medical Research and Education Trust Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin
AU2003287081A1 (en) * 2002-10-16 2004-05-04 Ilex Products, Inc. Clofarabine and taxane chemotherapy combination
JP4764165B2 (ja) * 2002-11-06 2011-08-31 サイクラセル リミテッド ドセタキセル及びｃｄｋ阻害剤を含む組合せ
EP1986632B1 (en) * 2006-02-10 2012-08-15 Nerviano Medical Sciences S.R.L. Combinations comprising a cdk inhibitor and a growth factor antibody or anti-mitotic
CN104220066A (zh) * 2010-11-19 2014-12-17 皮拉马尔企业有限公司 紫杉醇和cdk抑制剂药物组合物
JP6080837B2 (ja) * 2011-04-01 2017-02-15 アストラゼネカ アクチボラグ 療法的治療
KR102035361B1 (ko) 2011-11-30 2019-11-08 아스트라제네카 아베 암의 병용 치료
AU2013204533B2 (en) 2012-04-17 2017-02-02 Astrazeneca Ab Crystalline forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
FR2697752B1 (fr) * 1992-11-10 1995-04-14 Rhone Poulenc Rorer Sa Compositions antitumorales contenant des dérivés du taxane.
AU2195297A (en) * 1996-02-20 1997-09-02 Sloan-Kettering Institute For Cancer Research Combinations of pkc inhibitors and therapeutic agents for treating cancers

Similar Documents

Publication Publication Date Title
JP2024109585A5 (enExample)
JP2005500357A5 (enExample)
JP2006504723A5 (enExample)
EP1635762A4 (en) LOW-DOSED PHARMACEUTICAL POWDER FOR INHALATION
CY1115484T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson
JP2015524444A5 (enExample)
NO20065904L (no) Terapeutiske forbindelser
NO20055880L (no) Memantin orale doseringsformer
EP1574215A4 (en) SOLID ARZNEI FOR ORAL ADMINISTRATION
JP2006514116A5 (enExample)
JP2005508963A5 (enExample)
JP2004521140A5 (enExample)
JP2005530735A5 (enExample)
PL1680112T3 (pl) N-(5-adamantan-1-ylometoksypentylo)deoksynojirimycyna lub dopuszczalna farmaceutycznie sól stosowane w leczeniu oporności na insulinę
JP2006503095A5 (enExample)
JP2005507888A5 (enExample)
JP2002326936A5 (enExample)
JP2005505605A5 (enExample)
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
NZ527655A (en) Combination of a taxane (docetaxel) and a cyclin-dependent kinase inhibitor (flavopiridol)
JP2007538066A5 (enExample)
CY1114250T1 (el) Ακετυλ l-καρνιτινη για την προληψη της επιπονης περιφερικης διαβητικης νευροπαθειας
JP2010519274A5 (enExample)
EP1485077A4 (en) DRUGS COMBINATION THERAPY
RU2007111754A (ru) Применение мидостаурина для лечения желудочно-кишечных стромальных опухолей